DRKS00020516招募中未知
Bringing empirically supported treatments to children and adolescents after child abuse and neglect - BESTFORCA
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 116
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- one 至 one(—)
- 性别
- All
入选标准
- •In this study, there are two levels of participants with their respective inclusion criteria.
- •I) Psychotherapists (planned n = 116) inclusion: (1.) work as a (PIT) in one of the collaborating state approved postgradual psychotherapy training institutes (SAPPTIs) or as a LPT in one of the selected regions who (2) are willing to participate in the study and give informed consent.
- •II) Patient (planned n = 580) inclusion: (1.) age 5-20 years; (2.) experience of abuse or neglect (3.) clinical diagnosis of maltreatment-related PTSD according to the diagnostic criteria of ICD-10, or any mental disorder and at least a score of 21 on the Child and Adolescent Trauma Screen (CATS-2); (4.) travel time from their place of living to the treatment site less than one hour; (5.) patients and caregiver are willing to participate in the study and give informed consent; (6.) at least one caregiver is available and committed to attending the regular treatment sessions.
排除标准
- •In this study, there are two levels of participants with their respective exclusion criteria.
- •I) Psychotherapist exclusion: the time available before the end of their training program (PIT) or their retirement (LPT) is insufficient for the training and the treatment of the patients. Time is deemed insufficient in case a PIT has less than 12 months of training at the SAPPTI’s outpatient unit before the expected graduation from the training course and in case of an LPT if retirement or change of career is planned in less than 48 months from randomization.
- •II) Patient exclusion: (1.) severe mental retardation (intelligence quotient (IQ) of < 50; (2.) current psychosis, severe substance disorder or acute suicidality; (3.) any other current psychotherapy; (4.) stable psychotropic medication will be allowed but carefully monitored.
研究者
相似试验
已完成
2 期
Establishment of evidences for treatment of pediatric patients with Type 2 diabetes-Particularly optimal doses, effectiveness and safety of treatment with Metoformin.Pediatric patients with Type 2 diabetesJPRN-C000000216Establishment of evidences for treatment of pediatric patients with Type 2 diabetes-Particularly optimal doses, effectiveness and safety of treatment with Metoformin study groups.50
已完成
不适用
The evaluation of effectiveness of Cydonia oblonga syrup on clinical symptoms in patients with Gastroesophageal reflux diseasePediatric gastro-oesophageal reflux disease.Gastro-oesophageal reflux disease without oesophagitisIRCT2015030921388N1Shiraz University of Medical Sciences80
进行中(未招募)
不适用
TREATMENT STUDY FOR CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA - ICC APL STUDY 01EUCTR2008-002311-40-ITA.I.E.O.P. - ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA300
终止
不适用
An evidence-based intervention (Fit for Treatment”) to prevent cancer treatment-induced toxicities in cancer patients: An effectiveness-implementation hybrid studyAny histologically-confirmed diagnosis of cancerFatigueCognitive FunctionChemotherapy-induced Peripheral NeuropathyCardiovascular Disease RiskCancer - Any cancerNeurological - Other neurological disordersCardiovascular - Other cardiovascular diseasesACTRN12618000596202Tina Skinner41
已完成
不适用
An alternative approach for treatment of infantile esotropia with botulinum toxin A.NL-OMON39876Oogziekenhuis Rotterdam40
